Suggestions
Michael Shih
VP, Corporate Development at Kite Pharma
Michael Shih is a seasoned executive in the pharmaceutical industry with extensive experience in corporate development, business development, and licensing. He currently serves as the VP of Corporate Development at Kite Pharma, a position he has held since December 2022.1
Career Highlights
Current Role:: At Kite Pharma, Shih is responsible for licensing, collaborations, mergers and acquisitions (M&A), and other business development opportunities for the company's portfolio.1
Previous Positions::
- SVP, Head of Business Development at Biogen (July 2021 - December 2022)
- VP, Head of Global Transactions at Sanofi (January 2019 - July 2021)
- Head of Sanofi Genzyme Transactions (April 2018 - December 2018)
- Vice President of Business Development at Epizyme (September 2014 - September 2015)
- Senior Director and Director of Business Development at Eisai US (July 2007 - March 2012)
Education
Shih has a strong educational background in both science and law:
- J.D. from Fordham University School of Law (currently retired from law practice)
- M.S. in Biology from the University of Illinois at Urbana-Champaign
- B.S. in Molecular Biology from Cornell University1
Professional Expertise
Throughout his career, Michael Shih has demonstrated expertise in:
- Strategic business development
- Licensing and collaborations
- Mergers and acquisitions
- Alliance management
- Negotiation and execution of global business development transactions
His diverse experience across multiple pharmaceutical companies has given him a broad perspective on the industry and a strong foundation in corporate strategy and business development.1
